Both in Pharmaceuticals
Omeros vs Avalyn Pharma
Over the past year OMER returned −9.4% and AVLN returned −22.4%; their daily moves had a correlation of 0.35.
OMER −9.4% AVLN −22.4%Growth of $1, one year, split-adjusted
| Metric | OMER | AVLN |
|---|---|---|
| Price | $16.57 | $26.04 |
| Market cap | $1.20B | $1.15B |
| Today | −1.72% | −4.44% |
| 1 month | −17.7% | −8.8% |
| 6 months | +22.5% | — |
| Year to date | −3.5% | — |
| 1 year | +114.1% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | 97.2% | — |
| Net margin | 46.4% | — |
| P/E (TTM) | 9.6× | — |
| Price / sales | 31.2× | — |
| Net cash | $58.7M | $337.6M |
| Dividend yield | — | — |
| Volatility (60d) | 75.4% | — |
| Short % of float | 17.7% | 12.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).